C-reactive protein and complement components C3 and C4 in children with latent tuberculosis infection;C-reaktivni protein i komplement C3 i C4 u djece s latentnom tuberkuloznom infekcijom

Biochemia Medica

Volumn 18, Issue 1, 2008, Pages 52-58

  Dodig, Slavica ^a   Galez, Daniela ^b   Zoričić Letoja, Ivka ^a   Kristić Kirin, Branka ^a   Kovač, Kornelija ^a   Nogalo, Boro ^a   Živčić, Jadranka ^a   Zrinski Topić, Renata ^a  

^a SREBRNJAK CHILDREN S HOSPITAL   (Croatia)

^b KARLOVAC GENERAL HOSPITAL   (Croatia)

Author keywords

C reactive protein; Child; Complement C4; Complement G; Latent tuberculosis infection; Tuberculosis

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHILD CARE; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG RESPONSE; HUMAN; IMMUNOASSAY; INFANT; INFECTION PREVENTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MYCOBACTERIUM TUBERCULOSIS; PROTEIN BLOOD LEVEL; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 40749098567     PISSN: 13300962     EISSN: None     Source Type: Journal    
DOI: 10.11613/bm.2008.007     Document Type: Article

References (29)

1. World Health Organization. Global tuberculosis control: surveilleance, planning, financing. WHO Report 2005. Geneva, 2005.
2. Lalvani A, Pathan AA, McShane H, Wilkinson RJ, Latif M, Conlon CP, et al. Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T-cells. Am J Respir Crit Care Med 2001;163:824-8.
3. Mazurek GH, LoBue PA, Daley CL, Bernardo J, Lardizabal AA, Bishai WR et al. Comparison of a whole-blood interferon y assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. JAMA 2001;286:1740-7.
4. Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection. ATS/CDC Statement Committee on Latent Tuberculosis Infection Membership List, June 2000. Available at. http://www.cdc.gov/mmwr/ preview/mmwrhtml/rr4906a1.htm. Accessed December 27th 2007.
5. Bajaj G, Rattan A, Ahmad P. Prognostic value of C-reactive protein i tuberculosis. Indian Pediatr 1989;26:1010-3.
6. Pepys MB, Baltz MC. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol 1983;34:141-212.
7. Emery P, Luqmani R. The validity of surrogate markers in rheumatic disease. Br J Rheumatol 1993;32:Suppl 3:3-8.
8. Walker-Smith JA. Chronic inflammatory bowel disease in children: a complex problem in management Postgrad Med J 2000;76:469-72.
9. Lagerstrom F, Engfeldt P, Holmberg H. C-reactive protein in diagnosis of community-acquired pneumonia in adult patients in primary care. Scand J Infect Dis 2006;38:964-9.
10. Korppi M. Non-specific host response markers in the differentiation between pneumococcal and viral pneumonia: what is the most accurate combination? Pediatr Int 2004;46:545-50.
11. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003;107:363-9.
12. Coulon J, Willems D, Dorchy H. Increase in C-reactive protein plasma levels during diabetes in infants and young adults. Presse Med 2005;34:89-93.
13. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001;286:327-34.
14. Takemura M, Matsumoto H, Niimi A, Ueda T, Matsuoka H, Yamaguchi M, et al. High sensitivity C-reactive protein in asthma. Eur Respir J 2006;27:908-12.
15. Galez D, Dodig S, Raos M, Nogalo B. CRP in children with asthma and allergic rhinitis. Biochemia Medica 2006;16(2):163-9.
16. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003:111:1805-12.
17. Botto M. Links between complement deficiency and apoptosis. Arthritis Res 2001;3:207-10.
18. Boackle SA, Holers VM. Role of complement in the development of autoimmunity. Curr Dir Autoimmun 2003;6:154-6.
19. Boackle SA. Complement and autoimmunity. Biomed Pharmacother 2003;57:269-73.
20. Schlesinger LS, Bellinger-Kawahara CG, Payne NR, Horwitz MA. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. J Immunol 1990;144:2771-80.
21. MedCalc Download, Available at. www.medcalc.be/downlood.php. Accessed December 27th 2007.
22. Ito KM, Yoshiyama T, Wada M, Ogata H. C-reactive protein in patients with bacteriological positive lung tuberculosis. Kekkaku 2004;79:309-11. Available at; http://www.ncbi.nlm.nih.gov/pubmed/ Accessed August 7th 2007.
23. Peroš-Golubičić T. C-reactive protein in sarcoidosis. Acta Med lugosl 1991;45:169-74.
24. Koyanagi A, Kuffö, Gresely L, Shenkin A, Cuevas LE. Relationships between serum concentrations of C-reactive protein and micronutrients in patients with tuberculosis. Ann Trop Med Parasitol 2004;98:391-9.
25. Mueller-Ortiz SL, Wanger AR, Norris SJ. Mycobacterial protein HbhA binds human complement component C3. Infect Immun 2001; 69: 7501-11.
26. Velasco-Velazquez MA, Barrera D, Gonzalez-Arenas A, Rosales C, Agramonte-Hevia J. Macrophage - Mycobacterium tuberculosis interactions: role of complement receptor 3. Microb Pathog 2003;35:125-31.
27. Dubaniewicz A, Sztaba-Kania M, Hoppe A. Analysis of some immunological parameters in pulmonary tuberculosis. Pol Merkur Lekarski 2004;16:123-7.
28. Stokes RW, Haidl ID, Jefferies WA, Speert DP. Mycobacteria - macrophage interactions. Macrophage phenotype determines the nonopsonic binding of Mycobacterium tuberculosis to murine macrophages. J Immunol 1993;151:7067-76.
29. Starke JR. Tuberculosis in children. Semin Respir Crit Care Med 2004, 25:353-64.